Taking IBMD’s expertise in sensing, microfluidics and single-cell analysis, we are building advanced methodologies and devices for use in detection, prognosis and personalised treatment from liquid biopsy. We are developing technologies that assist with:
- CTC capture - microfluidic-based enrichment and capture
- CTC characterisation - advanced imaging AND deep single-cell cytometry (fluorescence and genomic) and novel microfluidics devices for functional analysis of CTCs
- Biomarker detection – advanced biofunctional probes for high-sensitivity detection of circulating biomarkers AND point-of-care devices
- Exosome analysis - microfluidics separation and characterisation platforms
- CtDNA detection – ultralow volume droplet-based assays and novel rapid sensing technologies
- miRNA detection – assay development for novel miRNA
We are excited to share the technologies with those looking to ask big biologically relevant questions.
This capability is currently supported by the:
|
|